IGI Logo

Innova Captab Limited, is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports, has garnered Rs. 171 crores from anchor investors ahead of its initial public offering that opens for public subscription on Thursday, December 21, 2023. The company informed the bourses that it allocated 3,816,963 equity shares at Rs. 448 per share on Wednesday, December 20, 2023, to anchor investors.

Foreign and Domestic Institutions who participated in the anchor were ICICI Prudential MF, Kotak Mahindra MF, Ashoka Whiteoak MF, SBI Life Insurance, 360 One MF, Bandhan MF, Canara Robeco MF, Aditya Birla Sun Life Insurance, Edelweiss MF, ITPL-Invesco MF, & others.

Out of the total allocation of 3,816,963 equity shares to the anchor investors, 1,713,030 equity shares were allocated to 6 domestic mutual funds through a total of 8 schemes amounting to Rs.

76.74 crore (approx.) i.e. 44.88% of the Total Anchor Book Size.

ICICI Securities Limited, and JM Financial Limited are the book running lead managers and KFin Technologies Limited is the registrar to the offer. The equity shares are proposed to be listed on BSE and NSE.

Above views are of the author and not of the website kindly read disclaimer